October 5, 2020 Artoss, Inc. Announces Record Sales of NanoBone Bone Graft »
April 24, 2019 Artoss, Inc. Announces FDA Clearance of NanoBone SBX Putty for Standalone Use in Posterolateral Spinal Fusion »
March 28, 2019 Artoss, Inc. Announces Hiring of Gabriel "Gabe" Ortiz as Director of Sales, Western Region
September 24, 2018 Artoss, Inc. Announces Hiring of William “Billy” Lapp as Director of Sales, East Coast. Further expansion of U.S. presence supporting commercialization
September 24, 2018 Artoss Announces Completion of $1 Million Funding Round. Financing allows expanded U.S. commercial and clinical presence
October 23, 2017 Artoss Announces NanoBone® QD Bone Graft. NanoBone QD allows for expanded orthopaedic clinical use
October 9, 2017 Artoss, Inc. Announces Hiring of Ryan O’Neill as Director of Sales, Eastern Region. Experienced Sales Background Supports NanoBone Efforts
September 15, 2017 Artoss, Inc. Announces DAPA Agreement for NanoBone® Bone Graft Products. Expands NanoBone U.S. Commercial Opportunities
November 8, 2016 Artoss Announces FDA Clearance to Market of NanoBone SBX Putty. Clearance Expands NanoBone role in U.S. Orthopaedic Surgery
